COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,832 Articles (22,553 medRxiv, 8,279 bioRxiv)

Most recent first Previous |  Page 934: Articles 9331-9340  | Next

Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
Wang, E., Chakraborty, A. K.
10.1101/2022.01.24.477469 — Posted: 2022-01-25
The Choice of Response Alternatives in COVID-19 Social Science Surveys
Wright, D., Wolff, S. M., Jaspal, R., Barnett, J., Breakwell, G.
10.1101/2022.01.24.22269741 — Posted: 2022-01-25
Harringtonine has the effects of double blocking SARS-CoV-2 membrane fusion
Hu, S., Wang, N., Chen, S., Ding, Q., Wang, C., Ma, W., Zhang, X., Wu, Y., Lv, Y., Xue, Z., Bai, H., Ge, S., He, H., Lu, W., Zhang, T., Ding, Y., Liu, R., Han, S., Zhan, Y., Zhan, G., Guo, Z., Zhang, Y., Lu, J., Gao, J., Jia, Q., Wang, Y., Lu, S., Zhang, H., He, L.
10.1101/2022.01.22.477323 — Posted: 2022-01-25
BASELINE METABOLIC PROFILING AND RISK OF DEATH FROM COVID-19
Murata, G. H., Murata, A. E., Campbell, H. M., Mao, J. T.
10.1101/2022.01.22.22269691 — Posted: 2022-01-25
Learnings from the Australian First Few X Household Transmission Project for COVID-19
Marcato, A. J., Black, A. J., Walker, J., Meagher, N., Price, D. J., McVernon, J., The Australian FFX Household Transmission Project Group
10.1101/2022.01.23.22269031 — Posted: 2022-01-25
A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives
May, T., Dawes, J., Fancourt, D., Burton, A.
10.1101/2022.01.24.22269530 — Posted: 2022-01-25
Border closure and travel restrictions to control the spread of COVID-19: an update to a Cochrane review
Abou-Setta, A. M.
10.1101/2022.01.22.22269686 — Posted: 2022-01-25
A qualitative process analysis of DCT as an alternative to self-isolation following close contact with a confirmed case of COVID-19
Denford, S., Martin, A. F., Towler, L., Mowbray, F., Essery, R., Bloomer, R., Ready, D. R., Love, N. K., Amlot, R., Oliver, I., Rubin, J., Yardley, L.
10.1101/2022.01.14.21267257 — Posted: 2022-01-25
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components
Jing, L., Wu, X., Krist, M. P., Hsiang, T.-Y., Campbell, V. L., McClurkan, C. L., Favors, S. M., Hemingway, L. A., Godornes, C., Tong, D. Q., Selke, S., LeClair, A. C., Pyo, C.-W., Geraghty, D. E., Laing, L. J., Wald, A., Gale, M., Koelle, D. M.
10.1101/2022.01.23.22269497 — Posted: 2022-01-25
Death review caused by Covid 19 in Bangladesh
Biswas, R. S. R., Nath, J. D., Nisha, F. E.
10.1101/2022.01.23.22269626 — Posted: 2022-01-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).